Dimensional Fund Advisors
AXSM icon

Dimensional Fund Advisors’s Axsome Therapeutics AXSM Stock Holding History

Dimensional Fund Advisors’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.55M Buy
22,670
+7,510
+50% +$1.63M ﹤0.01% 2509
2026
Q1 		$2.56M Buy
15,160
+2,729
+22% +$471K ﹤0.01% 2652
2025
Q4 		$2.27M Sell
12,431
-6,761
-35% -$944K ﹤0.01% 2711
2025
Q3 		$2.33M Buy
19,192
+11,849
+161% +$1.33M ﹤0.01% 2733
2025
Q2 		$767K Sell
7,343
-135
-2% -$14.3K ﹤0.01% 2929
2025
Q1 		$872K Buy
+7,478
New +$852K ﹤0.01% 2907

Other funds holding AXSM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Dimensional Fund Advisors's AXSM Position: Q2 2026 in Review

Dimensional Fund Advisors increased its Axsome Therapeutics (AXSM) stake by 50% in Q2 2026, buying an estimated $1.63M and bringing the position to 22,670 shares worth $5.55M. The position accounts for ﹤0.01% of the portfolio, ranked #2509.

Dimensional Fund Advisors first reported a position in AXSM in Q1 2025 and has held it in 6 quarters since. 506 funds tracked by Wall St. Rank hold AXSM as of Q2 2026.

  • Dimensional Fund Advisors held 22,670 shares of Axsome Therapeutics worth $5.55M as of Q2 2026.
  • Dimensional Fund Advisors bought 7,510 Axsome Therapeutics shares in Q2 2026, an estimated $1.63M.
  • Axsome Therapeutics made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q2 2026, its #2509 holding.
  • Dimensional Fund Advisors first reported a position in Axsome Therapeutics in Q1 2025 and has held it in 6 quarters since.
  • 506 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2026.

Based on Dimensional Fund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.